Human Papilloma Virus Vaccination Among Adolescents in a Community Clinic Before and After Intervention

Varman, Meera; Sharlin, C.; Fernández, Cristina; Vasudevan, Jayan; Wichman, Christopher

doi:10.1007/s10900-018-0467-3

Cited by 5 publications

(6 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this respect, also our review showed some differences in term of the impact on HPV vaccination coverage between males and females. Nevertheless, our results were not conclusive, as some papers showed better results in males [44,58,60,64] and vice versa [41,59,66].…”

Section: Strategies Identified Often Consisted Of One or More Interventions Including Reminders Education And Training Information Delivecontrasting

confidence: 85%

Section: Multicomponent Interventionsmentioning

confidence: 99%

“…Multicomponent strategies targeting both A/P and HCPs mostly included educational and training interventions (5; 83.3%) [61][62][63]65,66] and reminders (5; 83.3%) [61][62][63][64]66], followed by periodic feedback reports on coverage (3; 50%) [61][62][63]. All described positive effects in terms of both HPV initiation and completion [61][62][63][64][65][66], but only three of them (50%) reported significant results [63][64][65]. In particular, offering HPV vaccination in bundle with other vaccinations (tetanus toxoid, reduced diptheria toxoid, acellular pertussis-Tdap-and tetravalen meningococcal-MCV4) to all subjects attending a medical visit, together with the establishment of an internal immunization registry and standing orders/reminders before any visit, showed to increase both first-dose uptake and all-doses completion [64].…”

Section: Multicomponent Interventionsmentioning

confidence: 99%

See 2 more Smart Citations

Increasing HPV Vaccination Uptake among Adolescents: A Systematic Review

Acampora

Grossi

Barbará

et al. 2020

IJERPH

View full text Add to dashboard Cite

Human Papillomavirus (HPV) vaccination is a well-known fundamental strategy in the prevention of cervical cancer, as it is always caused by HPV infection. In fact, primary prevention of the infection corresponds to primary prevention of HPV-related cancers and other diseases. Since an effective prevention at the population level is the final goal, it is mandatory for healthcare systems to achieve a high HPV vaccination coverage among the adolescents to reduce the circulation of the virus and the burden of HPV-related diseases. This research identified, through a systematic literature review, 38 papers on strategies adopted to increase HPV vaccination coverage among adolescents. The evaluated strategies targeted adolescents/parents and/or healthcare providers and could be grouped in three main types: (1) reminder-based, (2) education, information, and communication activities, and (3) multicomponent strategies. Several types of strategy, such as those relied only on reminders and integrating different interventions, showed a positive impact on vaccination coverage. Nonetheless, the heterogeneity of the interventions suggests the importance to adapt such strategies to the specific national/local contexts to maximize vaccination coverage.

show abstract

Section: Strategies Identified Often Consisted Of One or More Interventions Including Reminders Education And Training Information Delivecontrasting

confidence: 85%

Section: Multicomponent Interventionsmentioning

confidence: 99%

Section: Multicomponent Interventionsmentioning

confidence: 99%

See 1 more Smart Citation

Increasing HPV Vaccination Uptake among Adolescents: A Systematic Review

Acampora

Grossi

Barbará

et al. 2020

IJERPH

View full text Add to dashboard Cite

show abstract

“…Quadrivalent HPV (qHPV) vaccine was approved by the FDA in June 2006 [11]. The vaccine commonly known as Gardasil is approved for females and males 9 through 26 years of age and contains types 16 and 18 (high risk) and types 6 and 11 (low risk) [12].…”

Section: Vaccinationmentioning

confidence: 99%

Identifying the Roles of Medical Providers when Addressing Barriers to HPV Vaccination Rates in Rural NE Clinics

Laudi¹

2022

JOGRS

View full text Add to dashboard Cite

Background: Although many interventions to address vaccine hesitancy until now have operated on the presumption that misperceptions are due to a lack of knowledge about HPV and the vaccine, this may not always be the reason behind vaccine hesitancy. Nyhan et. al found [1] that correcting myths about vaccines- such as autism links or vaccine side effects- do not increase vaccine rates among adolescents. Medical providers play a crucial role on influencing parents’ decision to vaccinate. In a study exploring how vaccination coverage among children 19-35 months old is associated with health care providers' influence on the parents' decision to vaccinate, parents who report their providers as being influential in the study are twice as likely to respond that vaccines are safe for children [2]. In the 2016 Clinical Report on Countering Vaccine Hesitancy by the American Academy of Pediatrics, motivational interviewing is listed as a potential communication technique that may be useful as pediatricians discuss vaccines with vaccine-hesitant parents. Research Question: The research attempting to find the best approaches to reverse the increasing rates of unvaccinated minors is limited and inconclusive. This project addressed the impact of medical providers’ attitudes of HPV vaccination on their early adolescent patient populations. Methods: Our cohort prospective study first examined medical providers’ baseline attitudes and approaches of HPV vaccination in privately insured clinics in rural areas of Nebraska. A survey was sent to eleven Phase III patient centered medical home (PCMH) NE clinics. The survey assessed medical staffs’ attitudes and approaches to HPV vaccination, particularly among specific patient age groups. In addition to each clinic’s collective survey responses, baseline HPV vaccination data was collected at eleven Phase 3 PCMH rural clinics in Nebraska for pediatric patients 11-15-years-old. The follow-up intervention implemented educational interventions in the clinics to increase HPV vaccination rates for pediatric patients 9-15-years-old. Our educational outreach program at the selected 10-13 clinics will serve as these rural clinics’ first efforts to selectively work toward improving HPV vaccination rates. Results: America’s Health Rankings (2017) found 42.4% of adolescents living in rural areas compared to 52.4% in urban areas are up-to-date on their HPV immunizations. The eleven rural clinics selected for the study show only a 0.9% completion of the vaccine series for 9-11-year-old patients (n=855), and 25.0% completion of the series for 12-15-year-old patients (n=1268) as of 2019. This implies a pressing health disparity that needs addressing in rural Nebraskan communities. 92.6% of all respondents chose the 12-15 age range as the patient population the clinics would typically ask about the vaccine versus 59.6% who chose the 9-11 age range. The most chosen reason for not mentioning the HPV vaccine is “parents previously voiced vaccine hesitancy” (33.3%) followed by “not enough clinic time” (22.2%). The most popular reason contributing to parental hesitancy is “they have concerns the vaccine is not safe for their child” (70.4%). The greatest benefit of the HPV vaccine was listed as “prevention from multiple forms of cancer” (33.3%) and the greatest drawbacks were both “multiple dose series completion” (40.7%) and “difficulty in convincing parents to vaccinate minors” (40.7%). The 9-11 age range was chosen as the most difficult age group to vaccinate (33.3%). The most difficult scenarios when addressing HPV vaccination concerns were “lack of vaccine education” (55.6%), “religious reasons against the vaccine (44.4%), and “language/cultural barriers” (37%). Qualitative results were also analyzed separately and focused on each individual clinic’s strengths and weaknesses regarding vaccination encouragement. Discussion: The baseline patient data show that clinics selected for the study exhibit a large disparity of HPV vaccination rates among a vulnerable age group. Survey responses show both a clinical observation regarding parents’ low-level education levels about the HPV vaccine as well as a lack of comfort engaging in open dialogue between patients and healthcare personnel. Focusing on these two variables alone could help increase rates of vaccination significantly. Survey results ultimately illustrate the urgent need for empirically-supported educational resources that will enhance communication- both within individual clinics among staff as well as between medical staff and patients’ families- to sustainably increase HPV vaccination rates across rural clinics.

show abstract

“…Human papillomavirus (HPV) is associated with skin and anogenital warts, as well as cervical, anogenital and oropharyngeal neoplasms [1, 2]. Modes of transmission include sexual and non-sexual contact, and in some parts of the world [3–7], HPV infection is considered to be the most common sexually transmitted disease.…”

Section: Introductionmentioning

confidence: 99%

Seroprevalence of HPV serotypes 6, 11, 16 and 18 in unvaccinated children from Mexico City

Pacheco-Domínguez

Durazo‐Arvizu²,

López-Hernández

et al. 2019

Epidemiol. Infect.

View full text Add to dashboard Cite

Data regarding humoral immunity against HPV infection are scarce. Most analyses focus on the identification of viruses on mucous membranes and primarily refer to women of reproductive age. The aim of this work was to estimate the seroprevalence of antibodies against HPV serotypes 6, 11, 16 and 18 among unvaccinated boys living in Mexico City. A cross-sectional study of 257 male students from 48 public primary schools in Mexico City, whose ages fluctuated between 9 and 14 years, was carried out. Immunological status was assessed by applying the competitive Luminex Immunoassay of HPV (cLIA). Among the study population, we initially found that 38.52% (n = 99) of the children tested positive against one or more of the HPV 6, 11, 16 and/or 18 serotypes. The most commonly found serotype was isolated HPV 18 or in combination with other serotypes (22% and 31%, respectively), followed by HPV 6 with frequencies of 4.7% and 11%, respectively; however, lower frequencies were estimated for HPV 16 (2%; 6%) and isolated HPV 11, 4%. If a second set of cut-off points for seropositivity is applied, the overall prevalence for any serotype is reduced to 15.2%. As it appears that a significant sector of the study population has had basal contact with an HPV serotype, we recommend considering the possibility of vaccination against HPV at earlier ages.

show abstract

Human Papilloma Virus Vaccination Among Adolescents in a Community Clinic Before and After Intervention

Cited by 5 publications

References 9 publications

Increasing HPV Vaccination Uptake among Adolescents: A Systematic Review

Increasing HPV Vaccination Uptake among Adolescents: A Systematic Review

Identifying the Roles of Medical Providers when Addressing Barriers to HPV Vaccination Rates in Rural NE Clinics

Seroprevalence of HPV serotypes 6, 11, 16 and 18 in unvaccinated children from Mexico City

Contact Info

Product

Resources

About